Earnings

AEON Biopharma Q2 EPS $(0.02) Beats $(0.12) Estimate

Aug 12, 2026 · 04:34 PM ET· updated 1h ago

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.12) by 83.33 percent. This is a 96.67 percent increase over losses of $(0.60) per share from the

Why It Matters

AEON Biopharma lost less money per share than experts predicted, which is good news. When a company doing research loses money slower than expected, it hints the company might be managing its spending well.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

AEON0.27

+0.00 (+0.37%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.